These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 3408224

  • 1. Controlled therapeutic trial of IgA nephritis with follow-up renal biopsies.
    Woo KT, Chiang GS, Yap HK, Lim CH.
    Ann Acad Med Singap; 1988 Apr; 17(2):226-31. PubMed ID: 3408224
    [Abstract] [Full Text] [Related]

  • 2. Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis.
    Woo KT, Edmondson RP, Yap HK, Wu AY, Chiang GS, Lee EJ, Pwee HS, Lim CH.
    Clin Nephrol; 1987 Feb; 27(2):56-64. PubMed ID: 3549083
    [Abstract] [Full Text] [Related]

  • 3. Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT.
    Shima Y, Nakanishi K, Kaku Y, Ishikura K, Hataya H, Matsuyama T, Honda M, Sako M, Nozu K, Tanaka R, Iijima K, Yoshikawa N, Japanese Pediatric IgA Nephropathy Treatment Study Group.
    Pediatr Nephrol; 2018 Nov; 33(11):2103-2112. PubMed ID: 29987456
    [Abstract] [Full Text] [Related]

  • 4. Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide.
    Tumlin JA, Lohavichan V, Hennigar R.
    Nephrol Dial Transplant; 2003 Jul; 18(7):1321-9. PubMed ID: 12808169
    [Abstract] [Full Text] [Related]

  • 5. Effect of fluvastatin and dipyridamole on proteinuria and renal function in childhood IgA nephropathy with mild histological findings and moderate proteinuria.
    Kano K, Nishikura K, Yamada Y, Arisaka O.
    Clin Nephrol; 2003 Aug; 60(2):85-9. PubMed ID: 12940609
    [Abstract] [Full Text] [Related]

  • 6. Effects of triple therapy in IgA nephritis: a follow-up study 5 years later.
    Woo KT, Lee GS, Lau YK, Chiang GS, Lim CH.
    Clin Nephrol; 1991 Aug; 36(2):60-6. PubMed ID: 1934661
    [Abstract] [Full Text] [Related]

  • 7. Combined therapy in children and adolescents with IgA nephropathy.
    Murakami K, Yoshioka K, Akano N, Takemura T, Okada M, Aya N, Hino S, Miyazato H, Yagi K, Maki S.
    Nihon Jinzo Gakkai Shi; 1994 Jan; 36(1):38-43. PubMed ID: 8107307
    [Abstract] [Full Text] [Related]

  • 8. Prospective trial of combined therapy with heparin/warfarin and renin-angiotensin system inhibitors in progressive IgA nephropathy.
    Ishii T, Kawamura T, Tsuboi N, Ogura M, Utsunomiya Y, Hosoya T.
    Contrib Nephrol; 2007 Jan; 157():114-9. PubMed ID: 17495447
    [Abstract] [Full Text] [Related]

  • 9. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
    McIntyre CW, Fluck RJ, Lambie SH.
    Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
    [Abstract] [Full Text] [Related]

  • 10. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
    Fernandes PF, Júnior GB, Barros FA, Sousa DC, Franco LM, Patrocínio RM.
    Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908
    [Abstract] [Full Text] [Related]

  • 11. Early intensive therapy for clinical remission of active IgA nephropathy: a three-year follow-up study.
    Hotta O, Taguma Y, Kurosawa K, Sudo K, Suzuki K, Horigome I.
    Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):967-73. PubMed ID: 8255008
    [Abstract] [Full Text] [Related]

  • 12. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial.
    Walker RG, Yu SH, Owen JE, Kincaid-Smith P.
    Clin Nephrol; 1990 Sep; 34(3):103-7. PubMed ID: 2225560
    [Abstract] [Full Text] [Related]

  • 13. Quantitative analysis of mesangial areas in serial biopsied patients with IgA nephropathy.
    Tateno S, Kobayashi Y.
    Nephron; 1987 Sep; 46(1):28-33. PubMed ID: 3600909
    [Abstract] [Full Text] [Related]

  • 14. Follow-up renal biopsies in IgA nephritic patients on triple therapy.
    Woo KT, Chiang GS, Lim CH.
    Clin Nephrol; 1987 Dec; 28(6):304-5. PubMed ID: 3442958
    [No Abstract] [Full Text] [Related]

  • 15. IgA nephritis in Singapore: clinical, prognostic indices, and treatment.
    Woo KT, Chiang GS, Lau YK, Lim CH.
    Semin Nephrol; 1987 Dec; 7(4):379-81. PubMed ID: 3445021
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of severe IgA nephropathy in children.
    Andreoli SP, Bergstein JM.
    Pediatr Nephrol; 1989 Jul; 3(3):248-53. PubMed ID: 2702102
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of methylprednisolone, cyclophosphamide in pediatric IgA nephropathy assessed by renal biopsy.
    Jiang XY, Mo Y, Sun LZ, Yue ZH, Chen SM, Wu W.
    Clin Nephrol; 2009 Jun; 71(6):625-31. PubMed ID: 19473630
    [Abstract] [Full Text] [Related]

  • 18. Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy.
    Tumlin JA, Hennigar RA.
    Semin Nephrol; 2004 May; 24(3):256-68. PubMed ID: 15156530
    [Abstract] [Full Text] [Related]

  • 19. Value of the Oxford classification of IgA nephropathy in children with Henoch-Schönlein purpura nephritis.
    Xu K, Zhang L, Ding J, Wang S, Su B, Xiao H, Wang F, Zhong X, Li Y.
    J Nephrol; 2018 Apr; 31(2):279-286. PubMed ID: 29185209
    [Abstract] [Full Text] [Related]

  • 20. Controlled trial of antiplatelet agents in mesangial IgA glomerulonephritis.
    Chan MK, Kwan SY, Chan KW, Yeung CK.
    Am J Kidney Dis; 1987 May; 9(5):417-21. PubMed ID: 3555016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.